Global Tissue Diagnostics Market to Reach US$ 9.4 Billion by 2032, Induced by Introduction of New Technologies

August 23, 2019 | Healthcare

According to the latest report by IMARC Group, titled “Tissue Diagnostics Market Report by Product Type (Instruments, Consumables), Technology (Immunohistochemistry, In Situ Hybridization, Digital Pathology and Workflow Management, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer, and Others), End-User (Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations, and Others), and Region 2024-2032”, the global tissue diagnostics market reached a value of US$ 5.5 Billion in 2023. Tissue diagnostics has been practiced across the globe for over a century. It is the process of staining and removing tissues for diagnosing a disease, and is mostly employed in oncology. The procedure is used for recognizing specific antigens that are present in preserved tissues. It consists of slicing thin tissue samples, which are treated with a stain of hematoxylin and eosin (H&E). These samples are then formalin-fixed paraffin-embedded (FFPE) in order to identify tumors and other specimens of histopathology. Tissue diagnostics help in detecting the existence of cancer and analyzing other features that may assist in making disease management decisions.

Global Tissue Diagnostics Market Trends:

With the emergence of network-based medicine, there has been a rise in the requirement of improvements across all facets of healthcare to enhance the detection, visualization and monitoring of diseases. Owing to this, several innovations have been made in the automation of novel platforms and staining equipment, such as digital immunohistochemistry (IHC), which is expected to play a vital role as an advanced laboratory information system (LIS). Besides this, the rising incidences of cancer have prompted governmental and non-governmental organizations across the globe to take initiatives for spreading awareness about the causes, prevention, diagnosis and treatment of cancer. For instance, in September 2018, WHO introduced the WHO Global Initiative for Childhood Cancer, which aims to reach nearly 60% survival rate for children with cancer. Such campaigns are creating a need for high-quality diagnostic services across both the developed and developing regions. Looking forward, the market is projected to reach a value of US$ 9.4 Billion by 2032, registering a CAGR of 5.9% during 2024-2032.

Market Summary:

  • The market has been bifurcated based on the product type, wherein consumables account for the majority of the market share.
  • On the basis of the technology, the market has been segmented into immunohistochemistry, in situ hybridization, digital pathology and workflow management, and special staining. Among these, immunohistochemistry represents the most preferred technology segment.
  • The market has been segregated according to the disease, which includes breast cancer, gastric cancer, lymphoma, prostate cancer, non-small cell lung cancer, and others. At present, tissue diagnostics is mostly employed for diagnosing breast cancer.
  • Based on the end user, the market has been categorized as hospitals, research laboratories, pharmaceutical companies, contract research organizations, and others. Hospitals currently exhibit a clear dominance in the market.
  • On a regional basis, North America is the leading market and holds the largest market share. Other regions include Europe, Asia Pacific, Middle East and Africa, and Latin America.
  • The competitive landscape of the market has also been examined with some of the key players being Roche, Danaher, Thermo Fisher Scientific, Abbott, Agilent Technologies, Merck, Sakura Finetek Japan, Abcam, BD, Qiagen, Bio SB, Biogenex, and Cell Signaling Technology.
     

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage  Product Type, Technology, Disease, End-User, Region
Region Covered North America, Europe, Asia Pacific, Middle East and Africa, Latin America
Companies Covered Roche, Danaher, Thermo Fisher Scientific, Abbott, Agilent Technologies, Merck, Sakura Finetek Japan, Abcam, BD, Qiagen, Bio SB, Biogenex and Cell Signaling Technology
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter: @imarcglobal

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Tissue Diagnostics Market to Reach US$ 9.4 Billion by 2032, Induced by Introduction of New Technologies
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARATI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More
DEinternational Egypt

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

Read More